Skip to main content
Premium Trial:

Request an Annual Quote

Advion Reaches OEM, Distribution Deal with CAMAG for TLC/MS Interface Product

NEW YORK (GenomeWeb News) – Advion said on Monday it has signed an exclusive original equipment manufacturing and distribution partnership deal with Swiss firm CAMAG for Advion's TLC/MS interface product.

The two companies plan to commercialize a combined system to Advion's Synthetic Organic Chemistry and Peptide Synthesis global market segments, Advion said, adding it has exclusive marketing and support rights in certain geographies, including North America and parts of Europe.

"TLC is used in reaction monitoring, flash method development … solvent selection, flash fraction confirmation, and impurity profiling," David Patteson, CEO of Advion, said in a statement. "The combination of the CAMAG TLC-MS Interface with the Advion expression CMS is a perfect integration of best-in-class chemist assay tools."

The expression compact mass spectrometer is targeted for the discovery research and process development synthetic organic chemistry market and can provide rapid compound confirmation in normal phase chromatography fractions.

Advion plans to launch the combined system at conferences in March and April, the Ithaca, NY-based company said.

Financial and other terms of the deal were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.